Su Yon Jung
About
Su Yon Jung is a scholar working on Oncology, Molecular Biology and Genetics.
According to data from OpenAlex, Su Yon Jung has authored 65 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 18 papers in Molecular Biology and 16 papers in Genetics. Recurrent topics in Su Yon Jung's work include Cancer Risks and Factors (21 papers), Metabolism, Diabetes, and Cancer (13 papers) and Growth Hormone and Insulin-like Growth Factors (10 papers). Su Yon Jung is often cited by papers focused on Cancer Risks and Factors (21 papers), Metabolism, Diabetes, and Cancer (13 papers) and Growth Hormone and Insulin-like Growth Factors (10 papers). Su Yon Jung collaborates with scholars based in United States, Saudi Arabia and Canada. Su Yon Jung's co-authors include Zuo‐Feng Zhang, Margaret Rosenzweig, Faina Linkov, Adam Brufsky, Susan M. Sereika, Joel L. Weissfeld, Eric M. Sobel, Jeanette C. Papp, Donald S. Burke and Derek A. T. Cummings and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.
In The Last Decade
Su Yon Jung
59 papers receiving 591 citations
Peers
Su Yon Jung
Yuyang Xu China
Cindy Ke Zhou United States
Chaofan Li China
Jillian H. Hurst United States
Kezia Gaitskell United Kingdom
Miriam Mutebi Kenya
Katherine Y. Tossas United States
Mulazim Hussain Bukhari Pakistan
Satyanarayana Labani India
Citations per year, relative to Su Yon Jung Su Yon Jung (= 1×)
peers
Yuyang Xu
Countries citing papers authored by Su Yon Jung
Since
Specialization
Citations
This map shows the geographic impact of Su Yon Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Yon Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Yon Jung more than expected).
Fields of papers citing papers by Su Yon Jung
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Su Yon Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Yon Jung. The network helps show where Su Yon Jung may publish in the future.
Co-authorship network of co-authors of Su Yon Jung
This figure shows the co-authorship network connecting the top 25 collaborators of Su Yon Jung. A scholar is included among the top collaborators of Su Yon Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Yon Jung. Su Yon Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Orenduff, Melissa C., Carl F. Pieper, Emma H. Allott, et al.. (2025). Plasma Insulin-like Growth Factor–Binding Protein-7 Is Positively Associated with Age, Obesity, Mortality, and Cancer in Postmenopausal Women. Cancer Epidemiology Biomarkers & Prevention. 34(6). 922–932.
2.
Hovey, Kathleen M., Chris Andrews, Curtis Miller, et al.. (2025). Genetic interleukin-6 receptor blockade, chronic disease risk, and longevity: results from the women’s health initiative. European Journal of Preventive Cardiology. 33(3). 381–390.
3.
Rapp, Stephen R., Ira Driscoll, Leslie V. Farland, et al.. (2025). Exploring biomarkers of neurodegenerative risk: associations of oxysterols, sex hormones, and reproductive characteristics in older women. Journal of Lipid Research. 66(12). 100938–100938.
4.
Nudy, Matthew, Aaron K. Aragaki, Xuezhi Jiang, et al.. (2025). Long-Term Changes to Cardiovascular Biomarkers After Hormone Therapy in the Women's Health Initiative Hormone Therapy Clinical Trials. Obstetrics and Gynecology. 145(4). 357–367.
5.
Simon, Michael S., Candyce H. Kroenke, Jessica L. Krok‐Schoen, et al.. (2024). Social Support, Social Strain, Stressful Life Events and Mortality Among Postmenopausal Women With Breast Cancer. Psycho-Oncology. 33(11). e70013–e70013.
6.
Beydoun, Hind A., May A. Beydoun, Rebecca L. Kinney, et al.. (2024). Pathways From Socioeconomic Factors to Major Cardiovascular Events Among Postmenopausal Veteran and Nonveteran Women: Findings From the Women's Health Initiative. Journal of the American Heart Association. 13(24). e037253–e037253.
7.
Jung, Su Yon, et al.. (2024). A Case of Non-small Cell Lung Cancer Who Complained of Abdominal Pain After Chemotherapy Improved by Complex Korean Medicine Treatment Including <italic>Gaewool-whadam-jeon</italic> - Case Report. The Journal of Internal Korean Medicine. 45(6). 1360–1373.
8.
Jung, Su Yon, et al.. (2024). DNA-methylation age and accelerated epigenetic aging in blood as a tumor marker for predicting breast cancer susceptibility. Aging. 16(22). 13534–13562.
9.
Zhang, Mingyan, Mia Hashibe, Jianyu Rao, et al.. (2023). Opium, phencyclidine, and crack cocaine smoking associations with lung and upper aerodigestive tract cancers: exploratory findings from a case-control study in Los Angeles County. The American Journal of Drug and Alcohol Abuse. 49(4). 440–449.
10.
Nelson, Rebecca A., Laura Kruper, Joanne Mortimer, et al.. (2023). Bilateral Oophorectomy and Colorectal Cancer Incidence and Mortality in the Women's Health Initiative. Cancer Epidemiology Biomarkers & Prevention. 32(11). 1668–1671.
11.
Peila, Rita, Xiaonan Xue, Michael J. LaMonte, et al.. (2023). Menopausal hormone therapy and change in physical activity in the Women's Health Initiative hormone therapy clinical trials. Menopause The Journal of The North American Menopause Society. 30(9). 898–905.
12.
Jung, Su Yon, Peter Scott, Jeanette C. Papp, et al.. (2020). Genome-wide Association Analysis of Proinflammatory Cytokines and Gene–lifestyle Interaction for Invasive Breast Cancer Risk: The WHI dbGaP Study. Cancer Prevention Research. 14(1). 41–54.
13.
Jung, Su Yon, Jeanette C. Papp, Eric M. Sobel, Herbert Yu, & Zuo‐Feng Zhang. (2019). Breast Cancer Risk and Insulin Resistance: Post Genome-Wide Gene–Environment Interaction Study Using a Random Survival Forest. Cancer Research. 79(10). 2784–2794.
14.
Jung, Su Yon, Jeanette C. Papp, Eric M. Sobel, & Zuo‐Feng Zhang. (2019). Post Genome-Wide Gene–Environment Interaction Study Using Random Survival Forest: Insulin Resistance, Lifestyle Factors, and Colorectal Cancer Risk. Cancer Prevention Research. 12(12). 877–890.
15.
Jung, Su Yon, Nicholas Mancuso, Jeanette C. Papp, Eric M. Sobel, & Zuo‐Feng Zhang. (2019). Post genome-wide gene-environment interaction study: The effect of genetically driven insulin resistance on breast cancer risk using Mendelian randomization. PLoS ONE. 14(6). e0218917–e0218917.
16.
Jung, Su Yon, Nicholas Mancuso, Herbert Yu, et al.. (2018). Genome-Wide Meta-analysis of Gene–Environmental Interaction for Insulin Resistance Phenotypes and Breast Cancer Risk in Postmenopausal Women. Cancer Prevention Research. 12(1). 31–42.
17.
Jung, Su Yon, Jeanette C. Papp, Eric M. Sobel, & Zuo‐Feng Zhang. (2017). Genetic Variants in Metabolic Signaling Pathways and Their Interaction with Lifestyle Factors on Breast Cancer Risk: A Random Survival Forest Analysis. Cancer Prevention Research. 11(1). 44–51.
18.
Jung, Su Yon, Mara Z. Vitolins, Jenifer I. Fenton, et al.. (2015). Risk Profiles for Weight Gain among Postmenopausal Women: A Classification and Regression Tree Analysis Approach. PLoS ONE. 10(3). e0121430–e0121430.
19.
Jung, Su Yon, Mara Z. Vitolins, Electra D. Paskett, & Shine Chang. (2014). Exogenous Estrogen as Mediator of Racial Differences in Bioactive Insulin-Like Growth Factor-I Levels Among Postmenopausal Women. The Journals of Gerontology Series A. 70(4). 495–502.
20.
Jung, Su Yon, Stephen D. Hursting, Michele Guindani, et al.. (2013). Bioavailable Insulin-like Growth Factor-I Inversely Related to Weight Gain in Postmenopausal Women Regardless of Exogenous Estrogen. Cancer Epidemiology Biomarkers & Prevention. 23(3). 534–544.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Yuyang Xu Breakdown of academic impact, for papers by Cindy Ke Zhou Breakdown of academic impact, for papers by Chaofan Li Breakdown of academic impact, for papers by Jillian H. Hurst Breakdown of academic impact, for papers by Kezia Gaitskell Breakdown of academic impact, for papers by Miriam Mutebi Breakdown of academic impact, for papers by Katherine Y. Tossas Breakdown of academic impact, for papers by Mulazim Hussain Bukhari Breakdown of academic impact, for papers by Satyanarayana Labani